<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>cure hiv - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/470504.xml</link>
<description>cure hiv - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>LiSAVIOR Placed on High Priority Status: Recruitment of Clinical Study Volunteer Names Begin</title>
     <link>http://www.prweb.com/releases/2008/05/prweb963224.htm</link><description>   <![CDATA[ <P>Dr. Roger Kenneth Hershline  PhD MD, CEO Global Humanceuticals, Inc. announced today that he has placed LiSAVIOR, an HIV drug in their development pipeline, into his company&#039;s High Priority status. Global Humanceuticals is highly interested to hear from prospective clinical trial participants from both the professional or treating group and the subject or treatment group. (PRWeb May 22, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb963224.htm">http://www.prweb.com/releases/2008/05/prweb963224.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/05/prweb963224.htm</guid>
        </item>
</channel>
</rss>